Log in
Enquire now
‌

US Patent RE39548 Interleukin-5 specific recombinant antibodies

Patent RE39548 was granted and assigned to Celltech R&D Limited on April, 2007 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
‌
Celltech R&D Limited
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
RE39548
Patent Inventor Names
Mark William Bodmer0
Diljeet Singh Athwal0
John Spencer Emtage0
Date of Patent
April 3, 2007
Patent Application Number
10012579
Date Filed
December 7, 2001
Patent Primary Examiner
‌
Sheela J. Huff
Patent abstract

An effective anti-IL-5 recombinant antibody molecule comprising heavy and/or light chain antigen-binding residues from a donor antibody.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent RE39548 Interleukin-5 specific recombinant antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us